Eni Confirms Interest in Biorefining Unit Minority Stake
By Christian Moess Laursen
Eni said it has received several preliminary expressions of interest for a minority stake in its biorefining unit Enilive.
The Italian oil-and-gas major said Thursday that a potential sale could be part of its satellite-model approach, by which it aims to develop units linked to the energy transition that can access capital markets and finance their own growth, in part through third-party funding.
An example of this strategy was the sale of a 9% stake in its low-carbon unit Plenitude for 700 million euros ($757.7 million) in December to investor Energy Infrastructure Partners.
Talks are at a too-early stage for Eni to provide further details on the Enilive stake interest, a spokesperson said.
Late Wednesday, Bloomberg reported the company was exploring the sale of a 20% stake in Enilive, and that it values the unit around 10 billion euros ($10.82 billion).
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
May 23, 2024 08:28 ET (12:28 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Is It Time to Ditch Your Money Market Fund for Longer-Term Bonds?
-
What’s Happening In the Markets This Week
-
4 Reasons Why Today’s Stock Market Is Delivering Impressive Performance
-
What Does Nvidia’s Stock Split Mean for Investors?
-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Tesla: Shareholder Vote Reduces Key Person Risk
-
After Earnings, Is CrowdStrike Stock a Buy, a Sell, or Fairly Valued?
-
Adobe’s Strong Quarterly Results Drive Share Gains
-
What Does Broadcom’s Stock Split Mean for Investors?
-
5 Ultracheap Stocks to Buy With the Best Returns on Investment
-
Broadcom Earnings: AI Sales Growth Accelerates
-
Oracle Earnings: IaaS Signings More Than Make Up for Miss
-
This Undervalued Stock Is a Buy After Its Dividend Increase